| Most of us are familiar
with Vitamin C, because of the work done on it originally by
Dr. Linus Pauling: he was convinced of its value both as a
suppresser of the common cold, and a fighter against cancer.
Certainly much modern research tends to support his position:
G. Block reported in the American Journal of Clinical
Nutrition in 1991, that there have been about 90 epidemiologic
studies , and the vast majority of them have found
statistically significant protective effects, particularly in
cancers of the esophagus, mouth, stomach, and pancreas, also
in cancers of the lung, breast, cervix and rectum. Those of us
who use vitamin C regularly to protect ourselves against the
onset of cold season hardly need to read any studies about it
- we KNOW!
Just recently a study was published that
seemed more to be a scare tactic than anything else: in fact,
the Council for Responsible Nutrition is quoted as saying that
the language of the press release is calculated to cause
concern and yet the amount of information provided does not
clearly justify that concern. Other researchers object that
this is only a preliminary study, the first ever report of any
negative effects from Vitamin C, flying in the face of years
of significant positive results in every variety of
study. It was a very small study, and only 30% of the
participants took Vitamin C, in unknown amounts ranging from
30 to 1000mg. No information was forthcoming about the number
of participants who actually were taking 500mg or more, nor
any measurements of the variability in the rates of any artery
hardening. I personally think this will turn out to be a
no-show, and it certainly hasn't affected the amount of
Vitamin C I take each day! Another riveting fact about this
study is that it is in direct opposition to a study published
in Circulation (the American Heart Association's
own journal) which found there to be a significant
reduction in carotid artery thickness/hardening
in people 55 or older who took 1,000 mg of Vitamin C a
day. Go figure, as they say!
The Vitamin C foundation points out that this
may very well be GOOD news! None of the information in
the study purported to show any obstruction or occlusion in
the arteries, just a thickening of the walls. Elderly
people tend to suffer inappropriate thinning of the blood
vessel walls as they age, and what this study may in fact be
showing is a PROTECTIVE effect from Vitamin C due to its
influence on collagen production.
Check out the entire story at http://www.internetwks.com/pauling/tale.html
An interesting fact about vitamin C is that
almost all other living things have the ability to manufacture
it in their bodies: man has lost the capability, leading
chemist Irwin Stone, who has studied Vitamin C since 1934, to
refer to this as a genetic flaw. He felt that where other
creatures have the ability to create the vitamin when the
onset of illness makes it necessary, (goats, who weigh
about the same as some humans, produce between 2.2 and 13.3
grams per day) humans have to supplement extra quantities
sometimes in doses as high as 10 grams - in fact, in acute
cases, holistic practitioners advocate giving vitamin C
intravenously and I have heard of amounts as high as 75 grams
being used with success. Obviously, this can only be done
under the care of a physician, since while the ease of
excretion makes Vitamin C toxicity unlikely, very high amounts
can cause some problems - mostly diarrhea. Some people use
this symptom as a guide to how much vitamin C their body
needs, referring to it as "bowel tolerance", and cutting back
a little on their dose when they reach that point.
Interestingly, a James Enstrom, PhD, recently published a
paper in Epidemiology showing a link between Vitamin C
supplementation and increased life span.
Some of the functions of vitamin C are:
the promotion of healing, formation of collagen, which makes
it important in periodontal disease, resistance to infection
and enhancement of the immune system, strengthening of blood
vessels, tissue growth and repair, the proper functioning of
the adrenal glands, protection against the effects of
pollution. These are very basic and essential things it does,
and an inadequate supply can be costly. A recent study (Jan
00) published in the Lancet and performed by the Boston
Univ. School of Medicine, and the Linus Pauling Inst., showed
that a dose of 500 mg per day can drop blood pressure in those
with mild to moderate hypertension by 9.1 percent, a figure
comparable to prescription drugs. Unfortunately, many common
things we encounter in this day and age deplete Vitamin C:
these include alcohol consumption and smoking, antibiotic use,
use of antihistamines and aspirin, also barbiturates,
cortisone , the use of oral contraceptives and estrogen, and
sulfonamides and prednisone. Stress is another things that can
deplete vitamin C levels, and very few of us are not subject
to that!
Recently, some very interesting research has
been done that suggests a symbiotic link between Vitamin C
& Vitamin E; i.e. that when they are both present
together in sufficient quantities, they do a more thorough job
of scavenging the damaging free radicals, as well as
supporting each other's revival cycles, whereby E & C are
not destroyed by their activity, but return to fight
again.
I sometimes have parents ask me what they can
do nutritionally to help with high levels of lead in the
blood, and am happy to be able to tell them that studies at
the San Francisco Vet Affairs Med Center and the University of
California San Francisco show that not only are low levels of
Vitamin C in the blood linked to high levels of lead, but that
increasing Vitamin C intake can help control even dangerously
high levels of lead.
I personally do not doubt at all that
supplementing with extra vitamin C may be one of the most
important steps an individual can take towards protecting
their health, and certainly never fail to take it
myself.
FOR MORE INFORMATION ON VITAMIN C
THAN YOU PROBABLY EVER WANTED, KEEP READING!
Dr Mercola weighs in on the latest Vitamin C
Attack!
More On the Concern Over
Vitamin C
“High doses of Vitamin C could
increase the risk of cancer, scientists warn
today….”
So begins the June 15th 2001 UK Daily
Mail front-page report, outlining the work of Dr Ian Blair,
resident researcher at the University of Pennsylvania
Pharmacology Unit. The Mail headline appears to be in direct
conflict with Dr Blair's own statement: "Absolutely, for God's
sake, don't say Vitamin C causes cancer." (Yahoo News,
Thursday June 14th, 2001)
But of course, The Mail and
others have shamelessly done exactly that. To the less
discerning reader, the story raises worrisome questions as to
the wisdom of high-level Vitamin C supplementation. If these
worldwide headlines have served any useful purpose at all, it
has been to confirm the moral/intellectual void currently
reigning in today's mass media 'news' departments.
At a
more fundamental level, why is Dr Blair conducting tests on
the efficacy of Vitamin C at all?
We are about to
discover that certain parties have a very definite interest in
casting aspersions upon Vitamin C.
Yet again, we are
being taught what to think about a certain subject, but not
how. To our knowledge, the information you are about to read
has not been included in any of the latest, and now worldwide
'Vitamin C Cancer Scare' headlines generated by Dr Blair's
findings.
A golden rule Dr Blair postulates that high
consumption of Vitamin C (a most beneficial adjunct in
non-toxic cancer recovery treatment) might actually cause
human tissue degeneration, which in turn could lead to a
heightened risk of contracting cancer.
And it is here
that we arrive at our first golden rule: when it comes to
assessing the veracity of any scientific claim, we must always
read between the lines we must search for what the
report does not say. We must especially be on the look-out for
those hoary old chestnuts, otherwise known as vested
interests. A University of Manchester research methodology
handbook contains the following valuable
advice:
"Science and research must be studied in the
context of all the interested parties involved. The questions
center on determining the relative weight of the various
allies in the 'fact-creating' process - e.g. funding bodies,
businesses, departments of state, professions and other
scientists.
In analyzing scientific debates, one should
always ask what social, institutional, political and
philosophical interests lie behind often apparently 'neutral'
and 'technical' knowledge claims." (University of Manchester
Institute of Science & Technology (UMIST) research
methodology course handout, 1994) (emphasis
mine)
On the matter of the 'fact creation' process,
renowned author John Le Carre recently stated:
"Big
Pharma [the industry in general] is engaged in the deliberate
seduction of the medical profession, country by country,
worldwide. It is spending a fortune on influencing, hiring and
purchasing academic judgment to a point where, in a few years'
time, if Big Pharma continues unchecked on its present happy
path, unbought medical opinion will be hard to find." (The
Nation, New York, Interview with John Le Carre, 9th April
2001)
Bought?
With the above in mind, lets put
Dr Blair's University of Pennsylvania under the spotlight and
see what encouragement Dr Blair might have had in taking his
extraordinary position and apparently misquoted position
against Vitamin C. We must ask the following questions: what
Big Pharma influences might there be supporting the University
of Pennsylvania Cancer Center (UPCC) and its mother ship, the
University of Pennsylvania Health Service?
What is the
relative weight of the funding bodies? If industry sponsorship
is taking place, are UPHS personnel free to exercise unbiased
critical thinking? Or are there grounds to suspect that UPHS
been 'bought' - that somewhere along the line, vested
interests have 'purchased academic judgment'?
Before
tackling the Vitamin C issue itself, the following UPHS
general statistics are very revealing.
Certain
Alliances
In May 2000, Dr Ian Blair's employers at
UPCC received a $26 million, five year Core Grant from the
National Cancer Institute (NCI) - the largest and most
influential conventional cancer treatment institution in the
world. In fact, UPCC has been continuously funded by the NCI
Core Grant mechanism since the grant was created by the
National Cancer Act in the early 1970's.
Currently,
UPCC is awash with more than $100 million in cancer research
funding: $37 million is from the National Cancer Institute;
$43 million from closely affiliated organizations, such as the
National Institutes of Health, the organization which actually
funded Dr Blair's Vitamin C research; another $12 million from
foundational support such as the American Cancer Society and
the Leukemia Society; and between $8 and $10 million from
various pharmaceutical companies.
Earlier, in June of
1999, UPCC received a $4.5 million gift from the William H.
Gates Foundation to research conventional treatments for
non-Hodgkin's lymphoma.
Aside from the Bill and Melinda
Gates connection, OncoLink, the University of Pennsylvania
Cancer Center,[28] is sponsored very generously by the
following corporations: Amgen, the world's largest independent
biotechnology company; Aventis, Ortho Biotech, Inc., Varian,
Inc., Janssen Pharmaceutica, AstraZeneca, Pharmacia Upjohn and
Pfizer. These corporations are very big indeed, and their
names represent no mean sponsorship committee.
More
Alliances
In March 2001, UPHS announced a strategic
alliance with Siemens Medical Systems, Inc. Under the terms of
the purchasing agreement, UPHS will make an initial discounted
purchase of cardiology, radiology and radiation oncology
equipment from Siemens, who will also service and maintain the
biomedical equipment already in place at designated UPHS sites
over the life of the agreement.
In the year 2000,
Siemens Medical Solutions, based in Iselin, New Jersey,
reported new orders of $5.65 billion, sales of $5.44 billion
and employs 27,000 worldwide. "This is the kind of alliance
that will be critical in our continuing financial recovery and
to assure our position as a leading national health system,"
said Robert D. Martin, Ph.D., Chief Executive Officer of
UPHS.
A good relationship with Siemens may well be
critical to UPHS' financial recovery, but does this kind of
dependent alliance foster the aforementioned necessary climate
for critical thinking?
What if there are privately held
UPHS reservations over the Siemens equipment, methodology or
ethos? Who will break rank first? Will anyone? What kind of
commercially gagged framework are the UPHS staff now locked
into with Siemens?
Yet More Corporate
Alliances
On April 26, 2001, UPCC announced a
business partnership with Integral PET Associates, the
nation's leading operator of fixed-site Positron Emission
Tomography (PET) cancer scanners. A patient receiving a PET
scan today is injected with a radiopharmaceutical, such as
flurodeoxyglucose (FDG), about 45 minutes before the scan,
which takes about two hours.
The radiopharmaceutical
tracer emits signals which are then picked up by the PET
scanner. A computer reassembles the signals into recognizable
images to determine if a cancer has spread, if a particular
treatment is effective, or if a patient is disease-free. IPA
will now be seeking to supply major hospitals throughout
Pennsylvania with this very expensive equipment. Installing
and operating a PET scanner typically costs around $1,600,000
in up-front capital costs, plus an additional $800,000 in
yearly staff and operational costs.
A short visit to
the UPHS website at www.med.upenn.edu will not only confirm
all of the above information, but will also confirm that these
alliances represent only a small percentage of the
long-standing conventional 'friendships' UPHS has fostered
with Big Pharma over the years. Given the strictly
conventional source of sponsorship monies received at UPHS,
what chance will the following statements have of being
'allowed' to feature on the UPHS cancer information
page?
"...as a chemist trained to interpret data, it is
incomprehensible to me that physicians can ignore the clear
evidence that chemotherapy does much, much more harm than
good." - Alan C Nixon, PhD, former president of the American
Chemical Society
"Doctors are too busy to dig into the
statistics of cancer treatments, they assume that what they
are taught at school or what is demonstrated in the pages of
briefing journals is the best treatment. They cannot afford to
suspect that these treatments are only the best for the
pharmaceutical companies that influence their 'institutions of
higher learning'." Paul Winter, The Cancell Home
Page.
"To the cancer establishment, a cancer patient is
a profit center. The actual clinical and scientific evidence
does not support the claims of the cancer industry.
Conventional cancer treatments are in place as the law of the
land because they pay, not heal, the best. Decades of the
politics-of-cancer-as-usual have kept you from knowing this,
and will continue to do so unless you wake up to this
reality." - Lee Cowden MD
"Almost every patient treated
with IL2 (a current conventional cancer treatment) suffered
fever, malaise, nausea or vomiting, diarrhea, sharp drops in
blood pressure, skin rashes, breathing difficulties, liver
abnormalities and irregularities in blood
chemistry.
Rosenberg himself details a number of
horrifying case histories, and one in particular where the
administration of IL2 had precipitated amongst other things,
vomiting, swollen joints, lung fluid and 'vascular leak
syndrome' where blood would ooze through the vessel walls and
collect under the skin." Steven Rosenberg, The Transformed
Cell, 1992. (IL2 is still used today.)
"Dr Linus
Pauling, often known as the 'Father of Vitamin C' and twice
awarded the Nobel Prize, declared that large intakes of up to
10g of the vitamin each day aids anti-cancer activity within
the body. Pauling was largely derided for making these
declarations, but today, large doses of Vitamin C are used by
many practitioners for cancer patients in nutritional therapy,
who believe Pauling was right and that the popular nutrient is
indispensable to the body in its fight to regain health from
cancer." Phillip Day, Cancer, Why We're Still Dying to Know
The Truth, Credence Publications, 2001.
"Do not let
either the medical authorities or the politicians mislead you.
Find out what the facts are, and make your own decisions about
how to live a happy life and how to work for a better world."
Linus Pauling http://www.cforyourself.com
The above
remarks are representative of a vast library of well-sourced
contrary information which sensibly questions the validity and
efficacy of conventional cancer treatments based on a huge
amount of clinical research and data. Naturally, with all
these expensive and patented treatments available to fight
cancer, the cancer rates should be going down. They are not.
They are increasing.
Staggering
Amounts
UPHS is totally locked into the
conventional cancer framework - a framework which today,
rightly stands accused of achieving no measurable success at
all in its approach to the treatment of cancer, immense
success in causing widespread, unnecessary death through its
application of lethal and highly toxic pharma-radiation
treatments, and even greater success in rewarding itself
absolutely staggering amounts of money in the whole grisly
process.
That these cancer corporations have become
incredibly wealthy through their 'chemo 'til we drop' approach
is a fact which Messrs Siemens, Zeneca, Upjohn, Glaxo, Rhone
Poulenc cannot deny.
Common Sense
Pauling
was right. We have been seriously misled. Taking the Siemens
$multi-million technology as an example, it may well detect
certain forms of cancer, but upon detecting it, what happens?
Quite simply, a bewildered, obedient, grateful and
unsuspecting cancer sufferer is then immediately directed
towards the door marked 'iatrogenic (doctor-induced) illness
and probable death.'
Closer examination clearly reveals
that the conventional path is fraught with toxic danger. But
the CEO of UPHS has made it quite clear that 'the Siemens
alliance [one of so many] is critical to the financial
security of UPHS'. Glad someone has their priorities
straight.
This is why we will hear no publicly
dissenting voices from UPHS as to the horrific realities
associated with 20th and 21st Century conventional cancer
treatments. The corporate big boys' riches must continue to
flow.. and a handsome proportion of it into the coffers of the
very dependent UPHS, of course, 'to assist in their financial
recovery'.
So Why the Slur on Vitamin
C?
As has already been stated, conventional cancer
treatment represents a $multi-billion a year industry. These
vast profits are fiercely protected by the industry giants.
But their treatments in no way address the underlying causes
of cancer.
Cancer is a nutritional/toxic/environmental
condition, which, in a great number of instances, can be
successfully reversed through the application of a sound
nutritional approach and common-sense lifestyle changes. Linus
Pauling, dubbed the father of Vitamin C, sensibly promoted the
benefits of consuming high doses Vitamin C in the prevention
of and battle against cancer.
Half-Truths and
Lies
So why aren't we hearing about these natural
treatment successes? Why aren't they being heralded across the
world? The answer is money.
Despite the multitudinous
successes in cancer regression through nutrition, and through
extensive application of vital elements such as Vitamin C,
Vitamin B17, pancreatic enzymes and other co-factors, Big
Pharma is doing all it can to silence these success stories.
To have it become widely known that cancer can be successfully
treated without toxic and profitable pharmaceuticals would be
catastrophic for its business.
Who would continue to
purchase these products? What would the Siemens, Glaxo and
Upjohn shareholders have to say about that? To their shame,
vested interests are keeping well-proven, non-toxic cancer
treatments from the public domain. This is why, under 'cancer
treatments' the UPHS website says this of vitamin
B17:
"Several patients displayed symptoms of cyanide
poisoning, including muscle weakness and impaired reflexes, or
had life-threatening levels of cyanide in their blood.
(Laetrile can release cyanide, which is a highly toxic
chemical.) The researchers concluded that Laetrile is not
effective as a cancer treatment and is harmful in some
cases."
But now read this contrary extract from a radio
talk show, featured in Phillip Day's Cancer, Why We Are Still
Dying To Know The Truth:
Radio host Laurie Lee: "So
this is verified, that laetrile [B17] can have this positive
effect?" Dr Ralph Moss: "We were finding this and yet, we in
Public Affairs were told to issue statements to the exact
opposite of what we were finding scientifically."
At
the time, Ralph Moss was former Assistant Director of Public
Relations at Memorial Sloan Kettering, NY, a leading American
conventional cancer research facility.
Of course
Laetrile, or Vitamin B17, is not approved by the FDA, but not
because it isn't beneficial it is, as the links provided
at the bottom of this report will demonstrate. No, Vitamin B17
has not approved by the FDA simply because the FDA have been
leaned on.
That's the way it goes in the
self-preserving, self-serving, conventional cancer business.
To put it bluntly, biddable FDA officials are only a phone
call and a golfing lunch away from the NCI and the NIH. A
classic example of these conflicts of interests and double
standards can be appreciated when one learns that sodium
fluoride is also not approved by the FDA due to its toxicity,
and yet drug giant Proctor and Gamble and others can market
the stuff in their toothpastes with complete
impunity.
The UPHS statement on Laetrile is a
fabrication. Such is the wealth of evidence overturning the
conventional stance on Laetrile and Vitamin C, that one can
only assume the UPHS statement falls into the following
category:
False Scientific Research Endangering the
Public
Doctors are fabricating research results to
win grants and advance their careers, but the medical
establishment is failing to protect the public from the menace
of these scientific frauds, a committee of medical editors
said yesterday. Eighty cases of fraudulent research have been
detected in the past four years, and 30 have been investigated
in the past year. In some cases, institutions have covered up
wrongdoing to protect reputations..
The Nub of
It
In an effort to subvert this mass-awakening to
the horrors of conventional cancer treatments, a devious
attack on all genuinely beneficial, natural (and therefore
un-patentable) anti-cancer products is now being waged by a
rather worried conventional cancer establishment The
ever-so-gentle slur on our most vital of vitamins, namely
Vitamin C, will soon be extended to a wide range of essential
minerals and vitamins.
This is just the beginning of
the subtle, but concerted attack. The latest conventional
legislation surrounding the codifying and banning of
efficacious natural treatments is being instituted, purely
because there is no money in it for Big Pharma. It is profit
before human health, but couched in respectable-looking,
'sciency' reports. And this veneer of respectability is
fooling the unsuspecting minions lower down the UPHS research
chain.
Naive
The two UPHS officials I
spoke to regarding Dr Blair's Vitamin C report were extremely
pleasant, open and helpful and displayed no intention to
supply misleading information. But both persons were entirely
locked into their superiors' way of thinking.
Media
Relations officer Olivia Fermano was curious as to my interest
into who funded the Vitamin C report. When I pointed out that
if Dr Blair's funding could be traced to a pharmaceutical
company producing conventional cancer treatments, then the
results would have to be very seriously questioned, Ms Fermano
was genuinely supportive.
"My goodness! That is a good
question. I will be right back to you." Her word-for-word
courteous reply, some two minutes later was as follows: "You
had me genuinely worried for a few minutes there, sir. But I
am pleased to tell you that our funding came directly from the
National Institutes for Health itself. I am so relieved." Ho
Hum.
Similarly, Dr Garret Fitzgerald, chair of UPHS
Center for Cancer Pharmacy Department stated: "The evidence
supporting Vitamin C as a useful adjunct in cancer treatment
ranges from scant to non-existent. Linus Pauling's work was
framed around a tenuous hypothesis only."
Whilst the
courtesy displayed by Ms Fermano and Dr Fitzgerald is
commendable, their naivety is the result of them both working
in a commercially cocooned workplace, purposefully insulated
from the many success stories attributed to non-toxic,
metabolic cancer treatments, and from the amazing health
benefits accrued from consuming a lot more Vitamin C than the
FDA's recommended daily intake of a miserable 60 mg
barely enough to keep one out of rags and scurvy.
Long
live Vitamin C and let's have even more of it! For a more
in-depth study of the conventional cancer industry, and of the
very good news concerning alternative cancer treatments,
readers are encouraged to visit www.credence.org and take the
cancer tour.
The above was extracted form the following
health
letter: http://credence.org/Eclub/200601c.htm
DR.
MERCOLA'S COMMENT:
This is a terrific followup to
the article that I posted on vitamin C a few weeks ago. It
reviews some of the politics involved with this
issue.
It was written by Phillip Day, who has written a
number of interesting books. Phillip was kind enough to send
me a few of his books Cancer, Why We are Still Dying to
Know the Truth World Without AIDS Health Wars
My
schedule has not provided time to read these yet, but I have
been quite impressed with his content and I am looking forward
to reviewing them as we both seem to be on the same
page.
Phillip was even kind enough to mention me a few
times in his last book.
©Copyright 1997-2001 by Joseph
M. Mercola, DO.
Before my article, here is a
response to the Univ. of Pennsylvania attack on Vitamin
C: it comes from the Vitamin C Foundation. ( www.vitamincfoundation.org/rebuttal.html)
COMMENT FROM LINUS PAULING
INSTITUTE:
Let us remember that this study is a test
tube experiment. The study does not describe biochemistry or
biology, and its relevance to reactions occurring in cells and
tissues of the human body is unknown. Many reactions of
vitamin C occur in vitro (in the test tube) that will not and
cannot occur in vivo (in the living
organism).
Why?
Because the physiological
environment of the cell and the body contains thousands of
substances that also react with vitamin C and rancid fats thus
derailing the chemistry observed in a test tube
system.
Rancid fats don't just wait around in vivo to
bump into a vitamin C molecule, but instead are very rapidly
reduced to harmless "alcohols" by a number of
enzymes.
Thus, the reaction rate of rancid fats with
these enzymes compared to the reaction rate of the rancid fats
with vitamin C is of crucial importance and this was not
measured in the Science study.
From what we know from
the study, incubations were done for two hours, an eternity in
biochemical terms. Enzymatic reactions as those indicated
above to reduce rancid fats to harmless alcohols that do not
react with vitamin C usually take a fraction of a second, not
two hours!
It is interesting to note that vitamin C
effectively inhibits the formation of rancid fats in the first
place. Thus, when your blood is exposed to oxidizing
conditions, vitamin C forms the first line of antioxidant
defense, and no lipid rancid fats are formed.
Rancid
fats begin to form only after vitamin C has been exhausted.
Thus, in these experiments rancid fats and vitamin C did not
exist simultaneously in blood, and thus never had the
opportunity to react with each other.
What's more, the
Science study used a concentration of rancid fats which in
biochemical terms was "a ton." Studies have shown that, in
blood, rancid fats exist in concentrations which are
10,000-fold lower than what was used in the Science
experiment. Again, this casts serious doubt on the relevance
of these results for living organisms.
To conclude from
this study that vitamin C causes cancer would be as
preposterous as to say that we have found a cure for cancer
based on a simple test tube experiment.
In fact, many
animal studies and cell culture experiments have demonstrated
anticancer effects of vitamin C, and the vitamin has been used
therapeutically in human cancer patients with some apparent
benefit.
Abstracted from Linus Pauling Institute
Release
Vitamin C Attacks
Continue
Who is behind these attacks Linus
Pauling Institute Attacks Vitamin C! Again we are faced
with a major media attack before any paper is published.
According to Ralph Moss in his book Antioxidants Against
Cancer, the authors of the last "Vitamin C Causes DNA Damage"
paper retracted their findings. This retraction was never
reported.
As the threat to the economic well being of
Medicine and major Pharmaceutical companies (from vitamin C)
increases, so do the groundless attacks designed to scare
people from taking Vitamin C.
If you doubt the impact
of vitamin C on medical profits, consider that after Linus
Pauling wrote his book on vitamin C in 1970, mortality from
heart disease decreased 30-40% in the USA. From around 741,000
deaths per year (National Center for Health Statistics,
Pauling 86, p 164) to less than 500,000 deaths per year. This
was an enormous economic loss for the segments of our society
that make money from heart disease.
Vitamin C
Foundation,
I've already figured out what is wrong
with the researcher's work, and I'm a rank amateur at
this.
The researcher dropped vitamin C into lipid
hyperoxide to see if it would produce genotoxic
materials.
Lipid hyperoxide is formed by free radical
damage on lipids.
People who take vitamin C DO NOT FORM
lipid hyperoxide because vitamin C is a free-radical
scavenger.
In addition, lipid hyperoxide does a huge
amount of bodily damage itself (such as heart disease plaques,
I believe), and anything that combines with it would, under
normal circumstances, be considered a good thing.
Thus
what this researcher did was to take a reaction out of context
using a scenario that cannot occur, and blamed vitamin C for
forming potentially harmful compounds from a particularly
nasty one. Typical bogus research.
Jon
Campbell
Can you imagine how Science mag. would have
responded if the said test-tube experiment had produced a
group of anti-cancer, tumor-inhibiting compounds? Of course,
they would have said "this needs further study and
corroboration with animal or clinical tests before we can
publish such a claim". Since the claim goes against Vitamin C,
they put out the red carpet. It really is a transparent lie
they have woven, fully understandable when you consider that
50% of the pages of Science mag. are composed of
advertisements for the bio-tech and pharm industry. Reminds me
when they were issuing all sorts of articles "proving" how
save and efficient nuclear energy was. James DeMeo,
Ph.D.
Knowledge of Health, Inc. 457 West Allen
Avenue #117 San Dimas, California 91773 Telephone:
909.861.3454 Fax: 909.861.3442 Email:
Bsardi@aol.com
For Immediate Release 6.16.2001 Contact:
Bill Sardi 909.861.3454
NEWS MEDIA AND
TEST-TUBE RESEARCHERS OVERLOOKED FAVORABLE
HUMAN STUDIES ON VITAMIN C
SAN DIMAS, CA-
Researchers at the University of Pennsylvania Center for
Cancer Pharmacology and the news media overlooked five
separate human studies that disproved high-dose vitamin C
causes DNA damage and instead chose to make headlines out of a
sole test-tube study that concluded that a 200-milligram dose
of vitamin C could potentially cause cancer.
While
millions of Americans who take vitamin C supplements were
beginning to question whether high-dose vitamin C is safe, Ian
A. Blair, the lead researcher in the study published in June
15 issue of Science magazine, was unavailable for comment and
is travelling outside the country, leaving an air of
uncertainty in the public's mind regarding vitamin
C.
Usually test-tube studies precede animal or human
studies, and results in the laboratory often do not coincide
with those found in living systems. In this case, human
studies had already been performed and have, as expected, not
confirmed the notion that vitamin C is toxic to living cells
or DNA.
Even though researchers are a bit puzzled as to
why vitamin C supplements do not always reduce the risk for
cancer, there are no studies that confirm that vitamin C
supplement users are at greater risk for cancer.
Report
overlooked contrary data
The report in Science was
submitted in early February and approved for publication in
May of 2001, and included other published references dated as
late as the year 2000. Four of the five human studies that do
not confirm that vitamin C causes DNA damage were published in
2000, and could have been cited by the authors of the report
in Science, but were overlooked.
The five overlooked
studies
For example, researchers at Johns Hopkins
University could not find evidence of a "significant main
effect or interaction effect on oxidative DNA damage in
non-smoking adults" with 500 milligrams/day of vitamin C
supplementation. [Cancer Epidemiology Biomarkers Prevention
2000 July;9:647-52]
Another study, conducted by
researchers in Germany found that 1000 mg. of vitamin C
consumed by smokers and non-smokers for 7 days did not produce
DNA damage as measured by the number of micronuclei in blood
lymphocytes. [Free Radical Research 2001
March;34:209-19]
In yet another study conducted by
Immunosciences Laboratory in California, twenty healthy
volunteers were divided into four groups and given either
placebo or daily doses of 500, 1,000 or 5,000 mg of ascorbic
acid for a period of 2 weeks. This study concluded that
"ascorbic acid is an antioxidant and that doses up to 5,000 mg
neither induce mutagenic lesions nor have negative effects on
natural killer cell activity, apoptosis, or cell cycle."
[Cancer Detection Prevention 2000;24: 508-23]
In London
researchers measured the effects of 260 milligrams/day of
vitamin C and vitamin C + iron in humans and concluded that
there was "no compelling evidence for a pro-oxidant effect of
ascorbate supple- mentation, in the presence or absence of
iron, on DNA base damage." [Biochemistry Biophysical Research
Communications 2000 November 2;277:535-40]
In Ireland,
researchers gave 1000 mg. of vitamin C to volunteers for 42
days and concluded that "supplementation with vitamin C
decreased significantly hydrogen-peroxide-induced DNA damage
in peripheral blood lymphocytes." [British Journal Nutrition
2000 August;84:195-202]
News media also
remiss
The news media was also remiss in not
checking whether there was any contrary data on this topic,
and did not interview other scientific sources, such as the
Linus Pauling Foundation, the Vitamin C Foundation, the
National Nutritional Foods Association or the Council for
Responsible Nutrition. Reuters Health and the Associated Press
health reporters ran the story without checking on the
validity of the report in Science. No explanation has been
given for this oversight, even though science reporters for
both organizations are well versed on medical topics. A cub
reporter could have uncovered the five contrary human studies
in a 30-minute search on Medline.
Similar erroneous
report in 1998
Recently researchers have been
exploring the dual nature of vitamin C. Is vitamin C a
pro-oxidant or rusting agent, or is it an antioxidant, a
cellular preservative? In 1998 Nature Magazine published a
similar report to the University of Pennsylvania study.
Researchers then claimed that high-dose vitamin C had
"rusting" properties in living cells and that 500 milligrams
of vitamin C was found to oxidize guanine, one of the four
bases that make up DNA. But the researchers overlooked that
high-dose vitamin C also increased the level of guanine,
another of the nucleic acids in DNA. The researchers failed to
point out their paradoxical results and the news media made
headlines out of the story then, as they are doing now. No
corrections were ever published. The mistaken impression left
on the public then was that high-dose vitamin C is potentially
dangerous.
It remains unclear whether the researchers
at the University of Pennsylvania Center for Cancer
Pharmacology will clear the air on their report, which
received worldwide headlines. ####
June 14,
2001
TO: Will Dunham, health reporter for REUTERS,
Washington DC will.dunham@reuters.com
FROM: Bill
Sardi Knowledge of Health, Inc. Independent health
journalist Diamond Bar,
California Bsardi@aol.com
I have questions regarding
your recent report which alleges that vitamin C supplements
beyond 200 milligrams per day may promote DNA damage that
could cause cancer.
1. Were you aware this is not a new
story, and that researchers can create DNA damage in test
tubes, but not in living systems, with many essential
nutrients or food factors found in the diet?
2. Why
didn't your report carry interviews with those who have a
differing opinion? Interviews could have been conducted with
the Vitamin C Foundation, or the National Nutritional Foods
Assn., or the Council for Responsible Nutrition? Did you seek
to obtain balanced information?
3. Why did Reuters
select this report from Science Magazine, and why did it run
with the headlines "Vitamin C Found To Promote Cancer-Causing
Agents?" rather than "Researchers study dual role of vitamin C
in cancer???"
4. What do you think the impact of your
report will be on the public at large, since many people take
vitamin C supplements in doses that exceed what your article
suggests as safe?
5. Are you aware of reports which
show that consumption of vitamin C beyond 300 milligrams per
day causes a major reduction in the risk of cataracts, and
beyond 500 milligrams per day reduces the risk of
hypertension? These dosages would generally required
supplements rather than foods.
6. Are you aware that,
in July of 2000, researchers found that supplementation of
diet with vitamin C (500 mg/day) had no significant main
effect or interaction effect on oxidative DNA damage as
measured by urinary 8-OHdG in nonsmoking adults. [Cancer
Epidemiol Biomarkers Prev 2000 Jul;9(7):647-52] In other
words, high-dose vitamin C did not produce any measurable DNA
damage.
The very issue of whether vitamin C promotes
DNA damage was undertaken in 1998 by researchers at the
International Antioxidant Research Centre, Department of
Pharmacology, King's College, London, United Kingdom. [Biochem
Biophys Res Commun 1998 May 8;246(1):293-8] They reported on
the effects of co-supplementing healthy volunteers with iron
(14 mg/day ferrous sulphate) and vitamin C (either 60 mg/day
or 260 mg/day as ascorbic acid) on levels of oxidative DNA
damage in white blood cells. The subjects were divided into
two groups: one group of 20 volunteers with a higher mean
initial level of plasma vitamin C (71.9 +/- 14.0 mumol/l) and
a second group of 18 volunteers with a lower mean level (50.4
+/- 25.8 mumol/l). In the first group there was a significant
rise in several oxidative DNA base damage products and in
total oxidative DNA damage in DNA extracted from white blood
cells, but not in 8-hydroxyguanine, after 6 weeks of
supplementation. However, after 12 weeks levels returned
approximately to normal. In the group with the lower initial
level of plasma ascorbate, presupplemental levels of oxidative
DNA damage were higher and decreased on supplementation with
iron and ascorbate.
A recent study, reported in the
January issue of Cancer Epidemiology Biomarkers, indicates,
among 711,891 men and women in the United States, followed
from 1982 thru 1996, regular use of vitamin C supplements,
even long-term use, was not associated with colorectal cancer
mortality. The combined-sex rate ratios were 0.89 for 10 or
more years of vitamin C use, a slight reduction in the risk
for cancer. In subgroup analyses, use of vitamin C supplements
for 10 or more years was associated with decreased risk of
colorectal cancer mortality before age 65 years, 52% relative
reduced risk, and 60% reduced risk reduced risk for rectal
cancer mortality. [Cancer Epidemiol Biomarkers Prev 2001
Jan;10(1):17-23]
In India researchers used high-dose
vitamin C in animals exposed to cigarette smoke and found that
vitamin C supplementation increased resistance to lipid
peroxidation and "this study seems to suggest that an intake
of a mega dose of vitamin C can protect the liver from oxidant
damage caused by cigarette smoke." [J Appl Toxicol 1997
Sep-Oct;17(5):289-95]
In 1999 researchers at the Fred
Hutchinson Cancer Research Center in Seattle reported that
supplement use in 697 incident prostate cancer cases (ages
40-64) identified from the Puget Sound Surveillance,
Epidemiology and End Results program registry. Adjusted odds
ratios vitamin C, 0.77 (range 0.57 - 1.04), about a 23%
relative reduced risk. The researchers said: "Overall, these
results suggest that multivitamin use is not associated with
prostate cancer risk." [Cancer Epidemiol Biomarkers Prev 1999
Oct;8(10):887-92]
Any cub reporter could have found
these reports in just 30 minutes on Medline. Why weren't
reports like these incorporated into your report? In light of
these scientific studies, would you call your report fair and
balanced? Shame on the Linus Pauling Institute
The
latest attack quotes so-called authorities at the Linus
Pauling Institute. If these quotes are accurate, the institute
now uses Pauling's name, but lacks his spirit. Dr. Frei has
not read Pauling's HOW TO LIVE LONGER AND FEEL BETTER, else he
would not make such inaccurate statements using Pauling's
name. We would ask any contributor to check with the Pauling
Institute, re-read HOW TO LIVE LONGER AND FEEL BETTER, and
reconsider giving the institute any more money until Dr. Frei
leaves his post.
REUTERS NEWS REPORT Thursday June
14 3:11 PM ET
Vitamin C Found to Promote
Cancer-Causing Agents
By Will
Dunham
WASHINGTON (Reuters) - Vitamin C, an essential
nutrient found in fruits and vegetables and taken in
large doses by many people as a dietary
supplement, is a double-edged sword, providing
benefits but also inducing the production of
compounds associated with cancer, researchers said on
Thursday.
Researchers at the University of Pennsylvania
added vitamin C, also known as ascorbic acid, to
solutions of a degraded version of an important fatty
acid found in blood, and found that it triggered the
production of DNA-damaging agents known to cause
mutations associated with a variety of
cancers.Lead researcher Ian Blair of the university's
Center for Cancer Pharmacology cautioned that the
study was conducted in a test tube and not with
living human cells or in actual
people.
``Absolutely for God's sake don't say vitamin C
causes cancer,'' Blair said in a telephone
interview.``
The key finding is that vitamin C can do
good things and bad things. And we've figured out
what the bad ones are. In terms of the impact, I think
it just redirects people's attention to the fact that
you can't replace a good diet with magic bullets such
as vitamin C.''The value of vitamin C has been the
subject of a long and heated debate in the scientific
community. One of the leading scientists of the 20th
century, Linus Pauling, who died at age 93 in 1994,
championed it as a tool for fighting cancer.But skeptics
argued that numerous studies have found that vitamin
C produced no benefit in combating cancer, and that
taking supplements actually could have
negative consequences. The new study appears to add
weight to those concerns.
CAUTION URGED ON DIETARY
SUPPLEMENTS
``Far more caution should be taken in the
use of dietary supplements -- and an insistence on
real proof that there's a benefit before undertaking any
of them,'' said Dr. Arthur Grollman, director of the
Laboratory for Chemical Biology at the State
University of New York at Stony Brook.``The
real, serious implication is that it (vitamin C)
could contribute to DNA damage that could cause
cancer,'' added Grollman, an expert in cancer causes who
was not involved in the study. ``It just adds more
evidence that there could be a significant risk to
ascorbic acid.''Blair said the study, which appears
in the journal Science, may explain why vitamin C has
shown little effectiveness at preventing cancer in
clinical trials.
Vitamin C is a water-soluble vitamin
that is important for bone and connective tissue
growth, wound repair and the function of blood vessels.
It is abundant in citrus fruits, green peppers,
tomatoes, cabbage and potatoes. The recommended U.S.
adult dietary allowance for vitamin C is 60
milligrams daily. Most supplements contain many times
that amount.Dr. Garret FitzGerald, director of the
University of Pennsylvania's Center for
Experimental Therapeutics, pointed to evidence of a
benefit from an overall healthy diet rather than
taking supplements on any particular nutrient.``We have
very clear evidence that eating a diet rich in
vegetables and fruits is a healthy thing in terms of
it being associated with a reduced incidence of cancer
and, indeed, heart disease, for that matter,''
FitzGerald said.
``On the one hand, I would say to
people there's no evidence to stop taking vitamin C
on the basis of these observations at this point in time. On
the other hand, I'd say consider very carefully what
the evidence is for taking vitamin C, which is
nonexistent. The better part of valor is: save
your money.''
VITAMIN C IS AN
ANTIOXIDANT
Vitamin C acts as an antioxidant
protecting against damage by ``free radicals'' -- highly
reactive ions produced by the breakdown of oxygen in cells. In
addition to damaging DNA directly, free radicals also can act
indirectly.They begin by converting linoleic acid, the major
polyunsaturated fatty acid in human blood plasma and the key
polyunsaturated fatty acid in certain cooking oils, into
another compound called a lipid hydroperoxide.When certain
metal ions are present as catalysts, the compound degrades
into DNA-damaging agents called genotoxins, which cause
mutations that have been found in human tumors. Blair said he
had a hunch that vitamin C might be capable of changing lipid
hydroperoxides into genotoxins. He added vitamin C to test
tube solutions of lipid hydroperoxides, using concentrations
comparable to those found in the human body if a person were
taking 200 milligrams a day.The study found that vitamin C was
more than twice as efficient as transition metal ions at
inducing the formation of genotoxins, including a particularly
potent variety.
Read About the Role of Vitamin C in
Heart Disease
Knowledge of Health, Inc. 457 West
Allen #117 San Dimas, California 91773 Phone:
909.861.3454 Fax: 909.861.3442 E-mail: Bsardi@aol.com For
Immediate Release Contact: Bill Sardi
909.861.3454
Who is Behind The Negative News Reports
On Vitamin C?
The news media features a report
published in Science magazine that high-dose vitamin C in a
test-tube causes DNA damage that could lead to cancer. It's
not news, since test-tube studies do not correlate with tests
conducted in living systems and the dual role of vitamin C as
both a pro-oxidant (rusting agent) and anti-oxidant (cell
preservative) has been published in scientific journals for
some time now. But it's a heralded news story that Reuters
Health and the Associated Press embellish with sensational
headlines. Instead of saying "Dual nature of vitamin C in
cancer explored," the headlines read "Vitamin C Found to
Promote Cancer- Causing Agents." It's yellow journalist at its
worst, since a quick search on Medline reveals that high-dose
vitamin C did not reveal any toxic by-products in human
studies. The toxic effect is only observed in test
tubes.
The lead university researcher, Ian Blair of the
University of Pennsylvania Center for Cancer Pharmacology, is
conveniently outside the country, so he can't easily respond
to questions. Ian Blair, covers his story by saying
"Absolutely, for God's sake, don't say vitamin C causes
cancer." But the headlines read otherwise.
The
University of Pennsylvania is the originator of Oncolink, a
prestigious online resource of cancer information. But who
sponsors Oncolink? Hidden behind the whole affair are
Oncolink's sponsors --- the pharmaceutical companies.
AstraZeneca, Amgen, Ortho Biotech, Pharmacia, Pfizer and
Janssen Pharmaceuticals. Are the drug companies using a major
university as their shill to spread misinformation about
vitamins?
It is becoming more obvious that
misinformation about vitamins, minerals and herbal products is
being planted in the news media and published in medical
journals in a calculated fashion. The reason is that more and
more Americans are taking health care into their own hands and
relying less and less on doctors and drugs to cure their ills.
The big secret is that the biological action of virtually
every prescription drug can be duplicated with nutritional
supplements at far less cost and with fewer side effects. The
only way to counter the growing demand for natural remedies is
to confuse the public with misinformation.
And the
misinformation campaign is working. The natural products
industry reports their growth has leveled off. Vitamin C sales
were off by 19.2 percent last year according to a report in
Natural Foods Merchandiser. In the past months dubious
negative reports have been published on garlic, St. John's
wort, and products containing ephedra. A characteristic of all
these reports is their emphatic conclusion that all previous
research which confirmed the validity of these natural
remedies is to be discarded because the latest scientific
report reached a contrary conclusion.
Last year the
news media made a front- page headline story out of a
presentation on vitamin C at the American Heart Association
meeting. The study wasn't even published and hadn't undergone
peer review, but the news agencies were quick to release a
factitious story that high-dose vitamin C could clog arteries
in the neck (the carotids). Vitamin C does not clog arteries,
but it does strengthen and thicken the walls of arteries via
its ability to promote collagen formation.
How do these
non-news stories get front-page coverage? It's simple. Public
relations agencies have bragged at seminars how they can take
a presentation at a medical meeting and get it aired on
television and published in newspapers. These publicity
agencies do the dirty work of planting misinformation in the
news media. It's propaganda, not news.
The natural
products industry is mounting its own public information
campaign, to counter negative news stories, and has hired
their own agency, Hill & Knowlton of Washington, D.C., to
air its side of the story.
There are simply no
standards of journalism being upheld here. Bad science gets
front-page coverage regardless of whether it is true or not.
Journalists aren't checking on the validity of medical
reports, and they aren't interviewing opposing views. In the
case of the recent vitamin C report, reporters did not
interview the National Nutritional Foods Association, the
Council for Responsible Nutrition, the Vitamin C Foundation,
nor the American Healthcare Products Association.
But
how long can the public be fooled? Why are the pharmaceutical
companies so afraid of a simple vitamin? It's because high
doses of vitamin C virtually eradicate the risk of developing
cataracts, eliminate the need for blood pressure medication,
reduce the need for anti-allergy drugs, reduce the risk of
gall stones, and produce many other health benefits. The drug
companies can't invent and patent a molecule as efficacious as
vitamin C. ####
TO: Owen Fonorow VITAMIN C
FOUNDATION
FROM: Bill Sardi
I just E-mailed this
inquiry to Ian A. Blair, the lead researcher of the now
infamous vitamin C report in Science
Magazine.
June 15, 2001
TO: Ian A.
Blair Center for Cancer Pharmacology University of
Pennsylvania ian@spirit.gcrc.upenn.edu
FROM: Bill
Sardi Health reporters, Nutrition Science
News Bsardi@aol.com Phone: 909.861.3454 Diamond Bar,
California USA
Unfortunately your paper in SCIENCE
regarding ascorbic acid and DNA damage was published while you
were out of the country and unavailable for quick comment. Of
course, it is disappointing that the news media made such
headlines out of research that does not appear to be new. The
issue of whether vitamin C is a pro-oxidant or anti-oxidant
has been debated for some time now. The fact that your paper
concluded from a test-tube study that vitamin C concentrations
equivalent to a 200 mg. dosage in humans could be genotoxic is
not confirmed by epidemiological or human studies which your
paper did not cite.
The submission date on your paper
was February 2001, and your paper cited other references as
late year 2000. The following reports, which includes reports
up to the year 2000, encompassing a review of human studies
with vitamin C and DNA damage, do not confirm your findings,
and should have been included in your paper, am I
correct?
I was wondering why your paper did not cite
these references and why you did not inform the news media
that your findings were not confirmed by human nor
epidemiological studies? Your comments to the news media left
the door open that it is possible for vitamin C to promote
cancer. The references below are for your review, with the
total abstracts following. Don't you think you should clear
this matter up by clarifying the conclusion from your paper in
light of other contrary research studies conducted outside of
test tubes?
For example, researchers at Johns Hopkins
University could not find evidence of a "significant main
effect or interaction effect on oxidative DNA damage as
measured by urinary 8-OHdG in non-smoking adults" with 500
milligrams/day of vitamin C supplementation. [Cancer Epidemiol
Biomarkers Prev 2000 Jul;9(7):647-52]
Another study,
conducted by researchers in Germany found that 1000 mg. of
vitamin C consumed by smokers and non-smokers for 7 days did
not produce DNA damage as measured by the number of
micronuclei in blood lymphocytes. [Free Radic Res 2001
Mar;34(3):209-19]
In yet another study conducted by
Immunosciences Laboratory, twenty healthy volunteers were
divided into four groups and given either placebo or daily
doses of 500, 1,000 or 5,000 mg of ascorbic acid for a period
of 2 weeks. This study concluded that "ascorbic acid is an
antioxidant and that doses up to 5,000 mg neither induce
mutagenic lesions nor have negative effects on NK cell
activity, apoptosis, or cell cycle." [Cancer Detect Prev
2000;24(6):508-23]
In London researchers measured the
effects of 260 milligrams/day of vitamin C and vitamin C +
iron in humans and concluded that there was "no compelling
evidence for a pro-oxidant effect of ascorbate
supplementation, in the presence or absence of iron, on DNA
base damage measured by GC-MS." [Biochem Biophys Res Commun
2000 Nov 2;277(3):535-40]
In Ireland, researchers gave
1000 mg. of vitamin C to volunteers for 42 days and concluded
that "supplementation with vitamin C decreased significantly
H2O2-induced DNA damage in peripheral blood lymphocytes." [Br
J Nutr 2000 Aug;84(2):195-202]
I await your
comment.
Cancer Epidemiol Biomarkers Prev 2000
Jul;9(7):647-52
The effects of vitamin C and
vitamin E on oxidative DNA damage: results from a randomized
controlled trial.
Huang HY, Helzlsouer KJ, Appel
LJ.
Department of Epidemiology, School of Hygiene and
Public Health, Johns Hopkins University, Baltimore, Maryland
21205-2223, USA.
Oxidative DNA damage may be important
in mutagenic, carcinogenic, and aging processes. Although it
is plausible that antioxidant vitamins may reduce oxidative
DNA damage, evidence from human studies has been sparse and
inconsistent. We determined the short-term effects of vitamin
C (500 mg/day) and vitamin E (400 IU d-alpha-tocopheryl
acetate/day) supplements on oxidative DNA damage in a
double-masked, placebo-controlled, 2x2 factorial trial in 184
nonsmoking adults. Mean duration of supplementation was 2
months. Oxidative DNA damage was measured by 24-h urinary
excretion of 8-hydroxy-2'-deoxyguanosine (8-OHdG). At
baseline, urinary 8-OHdG (mean +/- SE; ng/mg creatinine) was
associated with race (15.6 +/- 0.8 in African Americans versus
20.3 +/- 1.2 in Caucasians, P = 0.001), prior antioxidant
supplement use (18.6 +/- 0.8 in users versus 13.8 +/- 1.5 in
non-users, P = 0.007), and regular exercise (19.2 +/- 1.1 in
exercisers versus 16.6 +/- 0.9 in non-exercisers, P = 0.04).
Fruit and vegetable intake and serum ascorbic acid were
inversely associated with urinary 8-OHdG (P-trend = 0.02 and
0.016, respectively). The benefits of fruit and vegetable
intake became evident with the consumption being at least
three servings/day. At the end of supplementation, change from
baseline in urinary 8-OHdG (mean +/- SE; ng/mg creatinine) was
-0.6 +/- 1.4 (P = 0.61), 0.6 +/- 1.1 (P = 0.59), 0.5 +/- 1.0
(P = 0.61), and 1.6 +/- 1.4 (P = 0.27) in the placebo, vitamin
C alone, vitamin E alone, and combined vitamins C and E
groups, respectively. In overall and subgroup analyses, there
was no significant main effect or interaction effect of the
supplements on urinary 8-OHdG. In conclusion, supplementation
of diet with vitamin C (500 mg/day) and vitamin E (400 IU
d-alpha-tocopheryl acetate/day) had no significant main effect
or interaction effect on oxidative DNA damage as measured by
urinary 8-OHdG in nonsmoking adults. However, several aspects
of a healthy lifestyle were associated with lower oxidative
DNA damage.
Free Radic Res 2001
Mar;34(3):209-19
Protective Effects of Vitamins
C and E on the Number of Micronuclei in Lymphocytes in Smokers
and their Role in Ascorbate Free Radical Formation in
Plasma.
Schneider M, Diemer K, Engelhart K, Zankl
H, Trommer WE, Biesalski HK.
Fachbereich Biologie /
Abteilung Humanbiologie der Universitaet Kaiserslautern,
Germany.
Cigarette smoke is widely believed to increase
free radical concentrations causing subsequent oxidative
processes that lead to DNA damage and hence, to several
diseases including lung cancer and atherosclerosis. Vitamin C
is a reducing agent that can terminate free-radical-driven
oxidation by being converted to a resonance-stabilized free
radical. To investigate whether short-term supplementation
with the antioxidants vitamin C and E decreases
free-radical-driven oxidation and thus decreases DNA damage in
smokers, we determined the frequency of micronuclei in
lymphocytes in 24 subjects and monitored the electron
paramagnetic resonance signal of ascorbate free radical
formation in plasma. Further parameters comprised
sister-chromatid exchanges and thiobarbituric acid-reactive
substances. Twelve smokers and twelve non-smokers took 1000 mg
ascorbic acid daily for 7 days and then 1000 mg ascorbic acid
and 335.5 mg RRR-alpha-tocopherol daily for the next 7 days.
Baseline concentrations of both vitamins C and E were lower
and baseline numbers of micronuclei were higher (p <
0.0001) in smokers than in non-smokers. After 7 days of
vitamins C and E, DNA damage as monitored by the number of
micronulei was decreased in both, smokers and non-smokers, but
it was more decreased in smokers as indicated by fewer
micronuclei in peripheral lymphocytes (p < 0.05).
Concomitantly, the plasma concentrations of vitamin C (p <
0.001) as well as the ascorbate free radical (p < 0.05)
were increased. The corresponding values in non-smokers,
however, did not change. Our findings show that increased
ascorbate free radical formation in plasma after short-term
supplementation with vitamins C and E can decrease the number
of micronuclei in blood lymphocytes and thus DNA damage in
smokers.
Cancer Detect Prev
2000;24(6):508-23
New evidence for antioxidant
properties of vitamin C.
Vojdani A, Bazargan M,
Vojdani E, Wright J.
Immunosciences Lab, Inc, Beverly
Hills, CA 90211, USA.
This study was designed to
examine the effect of 500 to 5,000 mg of ascorbic acid on DNA
adducts, natural killer (NK) cell activity, programmed cell
death, and cell cycle analysis of human peripheral blood
leukocytes. According to our hypothesis, if ascorbic acid is a
pro-oxidant, doses between 500 and 5,000 mg should enhance DNA
adduct formation, decrease immune function, change the cell
cycle progression, and increase the rate of apoptosis. Twenty
healthy volunteers were divided into four groups and given
either placebo or daily doses of 500, 1,000 or 5,000 mg of
ascorbic acid for a period of 2 weeks. On days 0, 1, 7, 15,
and 21, blood was drawn from them, and the leukocytes were
separated and examined for intracellular levels of ascorbic
acid, the level of 8-hydroxyguanosine, NK cell activity, cell
cycle progression, and apoptosis. Depending on the subjects,
between a 0% and a 40% increase in cellular absorption of
ascorbic acid was observed when daily doses of 500 mg were
used. At doses greater than 500 mg, this cellular absorption
was not increased further, and all doses produced equivalent
increases in ascorbic acid on days 1 to 15. This increase in
cellular concentration of ascorbic acid resulted in no
statistically meaningful changes in the level of
8-hydroxyguanosine, increased NK cytotoxic activity, a reduced
percentage of cells undergoing apoptosis, and switched cell
cycle phases from S and G2/M to G0/G1. After a period of 1
week, with no placebo or vitamin washout, ascorbic acid levels
along with functional assays returned to the baseline and
became equivalent to placebos. In comparison with baseline
values, no change (not more than daily assays variation) was
seen in ascorbate concentrations or other assays during oral
placebo treatment. We concluded that ascorbic acid is an
antioxidant and that doses up to 5,000 mg neither induce
mutagenic lesions nor have negative effects on NK cell
activity, apoptosis, or cell cycle.
Biochem Biophys
Res Commun 2000 Nov 2;277(3):535-40
Potential
problems of ascorbate and iron supplementation: pro-oxidant
effect in vivo?
Proteggente AR, Rehman A, Halliwell B,
Rice-Evans CA.
Wolfson Centre for Age-Related Diseases,
GKT School of Biomedical Sciences, King's College London, St.
Thomas' Street, London, SE1 9RT, United Kingdom.
The
comparison was undertaken between the effects of ascorbate
versus ascorbate plus iron supplementation on DNA damage.
Twenty healthy subjects with initial levels of plasma
ascorbate of 67.2 +/- 23.3 micromol/l were randomly assigned
to and cycled through one of three supplementation regimes:
placebo, 260 mg/d ascorbate, 260 mg/d ascorbate plus 14 mg/d
iron for 6 weeks separated by 8-week washout periods.
Supplementation did not cause a rise in total oxidative DNA
damage measured by GC-MS. However, a significant decrease
occurred in levels of 8-oxo-7,8-dihydroguanine by ascorbate
supplementation and 5-hydroxymethyl uracil by both ascorbate
and ascorbate plus iron supplementation, relative to the
pre-supplemental levels but not to the placebo group. In
addition, levels of 5-hydroxymethyl hydantoin and 5-hydroxy
cytosine increased significantly, only relative to
pre-supplementation, by ascorbate plus iron treatment. No
compelling evidence for a pro-oxidant effect of ascorbate
supplementation, in the presence or absence of iron, on DNA
base damage was observed. Copyright 2000 Academic
Press.
Br J Nutr 2000
Aug;84(2):195-202
The effect of vitamin C or
vitamin E supplementation on basal and H2O2-induced DNA damage
in human lymphocytes.
Brennan LA, Morris GM, Wasson
GR, Hannigan BM, Barnett YA.
Cancer and Ageing Research
Group, School of Biomedical Sciences, University of Ulster,
Coleraine, Northern Ireland.
There is a wealth of
epidemiological information on antioxidants and their possible
prevention of disease progression but very little of the
research on antioxidants has involved intervention studies. In
this study, the potential protective effect of vitamin C or E
supplementation in vivo against endogenous and H2O2-induced
DNA damage levels in lymphocytes was assessed. The
supplementation involved fourteen healthy male and female
non-smokers mean age 25-53 (SD 1.82) years, who were asked to
supplement an otherwise unchanged diet with 1000 mg vitamin C
daily for 42 d or 800 mg vitamin E daily for 42 d. DNA damage
in H2O2-treated peripheral blood lymphocytes (PBL) and
untreated PBL before and after supplementation, and during a
6-week washout period was assessed using an ELISA. At each
sampling time-point, the red cell concentrate activities of
superoxide dismutase, catalase and glutathione peroxidase were
also determined. Supplementation with vitamin C or vitamin E
decreased significantly H2O2-induced DNA damage in PBL, but
had no effect on endogenous levels of DNA damage. The
activities of the antioxidant enzymes superoxide dismutase and
glutathione peroxidase were suppressed during the
supplementation period. These supplementation regimens may be
used to limit the possible adverse effects of reactive oxygen
species (including those produced during the course of an
immune response) on lymphocytes in vivo, and so help to
maintain their functional capacity.
Vitamin C Saved
250,000 lives last year |
RESOURCES
Other articles you may
find interesting:
For more articles
by the Vitamin
Lady click here.
|